| Previous close | 44.80 |
| Open | N/A |
| Bid | 43.95 |
| Ask | 46.95 |
| Strike | 380.00 |
| Expiry date | 2023-09-15 |
| Day's range | 44.80 - 44.80 |
| Contract range | N/A |
| Volume | |
| Open interest | 37 |
- Zacks
Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
- Zacks
The Zacks Analyst Blog Highlights Sanofi, Regeneron, AbbVie, Roche and Eli Lilly
Sanofi, Regeneron, AbbVie, Roche and Eli Lilly are included in this Analyst Blog.
- Zacks
Pharma Stock Roundup: SNY's COPD Study Meets Goal, ABBV Parkinson's Drug Gets CRL
Sanofi's (SNY) Dupixent succeeds in a pivotal study for COPD. FDA gives CRL to AbbVie's (ABBV) Parkinson's disease therapy, ABBV-951
© 2023 Yahoo. All rights reserved.
